Salinomycin encapsulated nanoparticles as a targeting vehicle for glioblastoma cells.

Salinomycin has been introduced as a novel alternative to traditional anti-cancer drugs. The aim of this study was to test a strategy designed to deliver salinomycin to glioblastoma cells in vitro. Salinomycin-encapsulated polysorbate 80-coated poly(lactic-co-glycolic acid) nanoparticles (P80-SAL-PLGA) were prepared and characterized with respect to particle size, morphology, thermal properties, drug encapsulation efficiency and controlled salinomycin-release behaviour. The in vitro cellular uptake of P80-SAL-PLGA (5 and 10 µM) or uncoated nanoparticles was assessed in T98G human glioblastoma cells, and the cell viability was investigated with respect to anti-growth activities. SAL, which was successfully transported to T98G glioblastoma cells via P80 coated nanoparticles (∼14% within 60 min), greatly decreased (p < 0.01) the cellular viability of T98G cells. Substantial morphological changes were observed in the T98G cells with damaged actin cytoskeleton. Thus, P80-SAL-PLGA nanoparticles induced cell death, suggesting a potential therapeutic role for this salinomycin delivery system in the treatment of human glioblastoma.

Encapsulated boron as an osteoinductive agent for bone scaffolds.

The aim of this study was to develop boron (B)-releasing polymeric scaffold to promote regeneration of bone tissue. Boric acid-doped chitosan nanoparticles with a diameter of approx. 175 nm were produced by tripolyphosphate (TPP)-initiated ionic gelation process. The nanoparticles strongly attached via electrostatic interactions into chitosan scaffolds produced by freeze-drying with approx. 100 µm pore diameter. According to the ICP-OES results, following first 5h initial burst release, fast release of B from scaffolds was observed for 24h incubation period in conditioned medium. Then, slow release of B was performed over 120 h. The results of the cell culture studies proved that the encapsulated boron within the scaffolds can be used as an osteoinductive agent by showing its positive effects on the proliferation and differentiation of MC3T3-E1 preosteoblastic cells.

Bone-like hydroxyapatite precipitated from 10×SBF-like solution by microwave irradiation.

Microwave-assisted methods have been frequently used in many processes owing to their numerous advantages such as performing fast, efficient and homogenous processes and reducing side reactions. In view of these benefits, in this study it was purposed to produce bone-like hydroxyapatite (HA) by inducing biomimetic process with microwave-irradiation. This is why, concentrated body fluid (SBF) i.e. 10×SBF-like solution was used and it was precipitated in different microwave powers i.e. 90W, 360W, 600W, and 1200W and in different exposure times. For comparison, precipitation process was also carried out at room temperature for 6h and at 80°C for 1h. The obtained HA structures were characterized by appropriate instrumental techniques. As a result, microwave-induced precipitation at 600W for 9 times 30s was determined as the optimum condition for the production of HA which has similar properties to the cortical bone. At this condition, B-type HA with 9.22% (wt.) carbonate content, 1.61 Ca/P molar ratio and amorphous structure was obtained easily, rapidly and efficiently. So, this is the first time microwave technology has been used to precipitate HA from SBF solution.